N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies.

scientific article published on May 2009

N-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ARDP.200800159
P698PubMed publication ID19415659

P50authorGiuseppe DaidoneQ42096934
Demetrio RaffaQ42791897
Manlio TolomeoQ73324269
P2093author name stringLucina Titone
Maria Grazia Cusimano
Claudia Colomba
Benedetta Maggio
Maria Valeria Raimondi
Salvatore Plescia
Stella Cascioferro
Domenico Schillaci
P2860cites workHomology model of the CDK1/cyclin B complex.Q45259068
P433issue5
P921main subjectmolecular designQ55213915
P304page(s)265-273
P577publication date2009-05-01
P1433published inArchiv der Pharmazie - Chemistry in Life SciencesQ10533542
P1476titleN-(indazolyl)benzamido derivatives as CDK1 inhibitors: design, synthesis, biological activity, and molecular docking studies
P478volume342

Reverse relations

cites work (P2860)
Q40506281Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana).
Q38808120The hunt for antimitotic agents: an overview of structure-based design strategies

Search more.